|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Current assets | ||||||||
| Cash and cash equivalents | ||||||||
| Marketable securities | ||||||||
| Accounts receivable, net | ||||||||
| Inventory | ||||||||
| Contract costs, current | ||||||||
| Prepaid expenses and other current assets | ||||||||
| Total current assets | ||||||||
| Property and equipment, net | ||||||||
| Operating lease right-of-use assets | ||||||||
| Contract costs, long-term | ||||||||
| Other non-current assets | ||||||||
| Total assets | ||||||||
| Liabilities and stockholders' equity | ||||||||
| Current liabilities | ||||||||
| Accounts payable | ||||||||
| Accrued liabilities | ||||||||
| Contract liabilities, current | ||||||||
| Operating lease liability, current | ||||||||
| Other current liabilities | ||||||||
| Total current liabilities | ||||||||
| Long-term liabilities | ||||||||
| Notes payable, long-term | ||||||||
| Contract liabilities, long-term | ||||||||
| Other liabilities, long-term | ||||||||
| Operating lease liability, long-term | ||||||||
| Total long-term liabilities | ||||||||
| Total liabilities | ||||||||
| Redeemable convertible preferred stock, $0.001 par value; Authorized shares: none and 46,624,838 shares as of December 31, 2024 and December 31, 2023, respectively Issued and outstanding shares: none and 17,817,643 shares as of December 31, 2024 and December 31, 2023, respectively Aggregate liquidation preference of none and $152,590 as of December 31, 2024 and December 31, 2023, respectively | ||||||||
| Stockholders' equity | ||||||||
| Common stock, $0.001 par value; Authorized shares: 500,000,000 as of June 30, 2026 and December 31, 2025, respectively Issued and outstanding shares: 38,223,221 and 37,485,124 as of June 30, 2026 and December 31, 2025, respectively | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated other comprehensive income (loss) | ||||||||
| Accumulated deficit | ||||||||
| Total stockholders' equity | ||||||||
| Total liabilities and stockholders' equity |
Loading...
